Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Inscripta
AddedFeb 13, 2024
UpdatedJun 18, 2026
Inscripta

Inscripta

Series A

Inscripta: Pioneering scalable digital genome engineering with an advanced, fully automated CRISPR-based platform.

HQ
Boulder, CO, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize genome engineering, Inscripta is pioneering scalable digital genome engineering through its advanced CRISPR-based platform. The company's core product, the GenoScaler™ Platform, integrates an instrument, consumables, software, and assays to offer a fully automated workflow for massively parallel, trackable editing of genomes. Inscripta aims to harness the power of biology and data science to bring affordable and sustainable synthetic biology products to market, focusing on industries such as biotechnology and pharmaceuticals.

Notable figures associated with Inscripta include leaders in genome engineering and synthetic biology. The company has attracted significant investment from prominent venture capital firms, enabling rapid advancements and scaling of their technology. Key achievements include the development of the MAD7® Nuclease and the successful deployment of their benchtop platform in various research settings. Inscripta's innovations have had a substantial impact on the field of synthetic biology, making genome editing more accessible and efficient.

Inscripta - Similar Companies

Synthego logo

Synthego

synthego.com

Mammoth Biosciences logo

Mammoth Biosciences

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Tome Biosciences logo

Tome Biosciences

tome.bio

Scribe Therapeutics logo

Scribe Therapeutics

scribetx.com

Metagenomi logo

Metagenomi

metagenomi.co

Volta Labs, Inc. logo

Volta Labs, Inc.

voltalabs.com

Gencove logo

Gencove

gencove.com

Crispr QC logo

Crispr QC

crisprqc.com

GenEdit logo

GenEdit

genedit.com

Ultima Genomics logo

Ultima Genomics

ultimagenomics.com

BioSkryb Genomics logo

BioSkryb Genomics

bioskryb.com

GeneTether logo

GeneTether

genetether.com

Inso Biosciences logo

Inso Biosciences

inso.bio

Cellanome logo

Cellanome

cellanome.com

Inscripta - Quick Facts

Who are Inscripta's competitors?

Companies similar to Inscripta include Synthego, Mammoth Biosciences, Ginkgo Bioworks and Tome Biosciences.

When was Inscripta founded?

Inscripta was founded in 2015.

Where is Inscripta's headquarters located?

Inscripta's headquarters is located in Boulder, CO, US.

When was Inscripta's last funding round?

Inscripta's most recent funding round was for $4.4M (USD) in January 2023.

How much has Inscripta raised to-date?

As of Jan 18, 2023, Inscripta has raised a total of $463.9M (USD).

How many employees does Inscripta have?

Inscripta has 178 employees as of Feb 4, 2024.

Inscripta - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • Automation
  • Crispr
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Genome Engineering
Tags
  • Biotech
  • GenAI
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified